This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ding, C. Articles by Jones, G. Search for Related Content PubMed PubMed Citation Articles by Ding, C. Articles by Jones, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Calcium and Bone Metabolism

Circulating Levels of Inflammatory Markers Predict Change in Bone Mineral Density and Resorption in Older Adults: A Longitudinal Study

Menzies Research Institute (C.D., G.J.), University of Tasmania, Hobart, Tasmania 7000, Australia; and Diabetes and Endocrine Services (V.P., J.B.) and Department of Clinical Chemistry (R.U.), Royal Hobart Hospital, Hobart, Tasmania 7001, Australia

Address all correspondence and requests for reprints to: Dr. Changhai Ding, Menzies Research Institute, Private Bag 23, Hobart, Tasmania 7000, Australia. E-mail: changhai.ding{at}utas.edu.au.

Context: IL-1, IL-6, and TNF- play an important role in the pathogenesis of osteoporosis in animals; however, evidence that these play a similar role in bone loss in human studies is limited.

Objective: Our objective was to determine the associations between serum markers of inflammation and changes in bone mineral density (BMD) and urinary pyridinoline (PYR) to creatinine (Cr) ratio over 2.9 yr in older adults.

Methods: A total of 168 randomly selected subjects (mean 63 yr, range 52–78, 48% female) was studied. BMD was measured by dual-energy x-ray absorptiometry at baseline (mean T score: –0.18 to –0.61) and 2.9 yr later. Serum high-sensitivity (hs) C-reactive protein (CRP), IL-6, TNF-, and the urinary PYR/Cr ratio were measured on both occasions.

Results: The mean annual loss of BMD was 0.15, 0.15, and 0.34% at total body, spine, and hip, respectively. Change in total body BMD was associated with baseline hs-CRP, IL-6, and TNF-, as well as change in hs-CRP (β: –0.41%/U, 95% confidence interval –0.68%, –0.15%) and IL-6 (β: –0.62%/U, 95% confidence interval –1.01%, –0.23%). If these markers were put in the same predictive model, only IL-6 remained largely unchanged. Changes in other BMD sites were significantly predicted by IL-6 (hip and spine) and TNF- (spine only). Finally, change in the PYR/Cr ratio was positively associated baseline IL-6, hs-CRP, and their changes (all P < 0.05) in women, but not men.

Conclusions: Variation within the low levels of inflammatory markers observed in this study, especially IL-6, predicts bone loss and resorption, suggesting that targeted antiinflammatory therapy has potential for the prevention of osteoporosis.

This article has been cited by other articles:

				T. C. Collins, S. K. Ewing, S. J. Diem, B. C. Taylor, E. S. Orwoll, S. R. Cummings, E. S. Strotmeyer, K. E. Ensrud, and for the Osteoporotic Fractures in Men (MrOS) Study Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men Circulation, May 5, 2009; 119(17): 2305 - 2312. [Abstract] [Full Text] [PDF]